Predict your next investment

INTERNET | Internet Software & Services / Advertising, Sales & Marketing

See what CB Insights has to offer

Founded Year



Acquired | Acquired

About is a physician network providing digital promotion and market research services to the life science industry. In August 2011, was acquired by M3 USA. Headquarter Location

90 Milton Park Abingdon

OX14 4RY,

United Kingdom

Latest News


Jun 6, 2014

Multiple Myeloma Debate 2014: Recent advances in multiple myeloma The one-month campaign is being delivered via a service called ClinTalk, which presents video and slide content in an easily digestible format to a clearly defined target audience. Myeloma UK has used ClinTalk to deliver a video from Graham Jackson, Professor of Clinical Haematology at the Newcastle Upon Tyne NHS Foundation Trust, on recognising the signs and symptoms of myeloma. Doctors viewing the video can be linked directly to the Myeloma Academy™ – an online learning initiative on the Myeloma UK website, which provides a one-stop resource to meet the evolving needs of healthcare professionals involved in the treatment and care of myeloma patients. Doctors are also encouraged to download a myeloma diagnosis pathway PDF and visit the Myeloma Academy™ and Myeloma UK website via the ClinTalk service. Dr Tim Ringrose, CEO of M3 Europe, said: ‘We are delighted that Myeloma UK has chosen ClinTalk to engage with GPs on myeloma, which is a complex and heterogeneous cancer with a myriad of co-morbidities. ‘ClinTalk is ideal for a campaign of this kind, since it enables clients to deliver information quickly to a target audience that can be broken down by specialty, geography or cross-matched against a target list.’ Eric Low, Chief Executive of Myeloma UK, said: ‘ has proved to be a great tool for delivering important information about suspecting and diagnosing myeloma to non-specialists. The ability to link from ClinTalk to The Myeloma Academy has helped us to further engage healthcare professionals interested in finding out more about this complex cancer. ‘Accessing the Myeloma Academy from ClinTalk provides them with educational resources that reflect the holistic needs of patients and  About M3: M3 is a trusted global provider of information and connections in healthcare. It has a reach to more than 2.5m physicians worldwide, via websites such as, , and – making it the world’s largest network of physicians. M3 provides data-driven, global programmes that use local knowledge, and harness technology to maximise efficiencies and deliver measurable outcomes. Through its commitment to progress and its investment in deepening connections, M3 will continue to break down the barriers that stand in the way of improvements and progress in healthcare. About myeloma Myeloma, also known as multiple myeloma, is a cancer caused by abnormal cells in the bone marrow. Every year, around 4,700 people in the UK are diagnosed with myeloma. In myeloma patients, the abnormal cells divide and expand and can cause a range of complications including bone damage, bone pain and fractures, kidney impairment, recurrent infection, anaemia and fatigue. There is currently no cure for myeloma but there are many very effective treatments and recently published statistics show that many patients live with myeloma for years, thanks to collaboration between industry the NHS and organisations like Myeloma UK. About Myeloma UK Myeloma UK is the only organisation in the UK dealing exclusively with myeloma, a bone marrow cancer for which there is no cure, but many very effective treatments. Our broad and innovative range of services cover every aspect of myeloma from providing information and support, to improving standards of treatment and care through research, education, campaigning and raising awareness. At Myeloma UK we are passionate and dedicated about what we do and have a relentless commitment to achieving our goals. We receive no government funding and rely almost entirely on voluntary donations and fundraising activities. More information on all of our work is available at For media information:Andrew Baud, Catherine McNulty or Lydia HaywardT: +44 (0) 20 3397 3383M: +44 (0) 7775 715775E:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces. is included in 1 Expert Collection, including ad tech.


ad tech

3,632 items

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.